MXPA05010135A - Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos. - Google Patents

Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos.

Info

Publication number
MXPA05010135A
MXPA05010135A MXPA05010135A MXPA05010135A MXPA05010135A MX PA05010135 A MXPA05010135 A MX PA05010135A MX PA05010135 A MXPA05010135 A MX PA05010135A MX PA05010135 A MXPA05010135 A MX PA05010135A MX PA05010135 A MXPA05010135 A MX PA05010135A
Authority
MX
Mexico
Prior art keywords
manufacture
pharmaceutical agents
oxazole derivatives
novel oxazole
novel
Prior art date
Application number
MXPA05010135A
Other languages
English (en)
Inventor
Rueth Matthias
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA05010135A publication Critical patent/MXPA05010135A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

El objeto de la presente invencion son compuestos de la formula general (I), (ver formula (I)), sus sales farmaceuticamente aceptables, formas enantiomericas, diastereoisomeros y racematos, la preparacion de los compuestos anteriormente mencionados, los medicamentos que los contienen y su fabricacion, asi como el uso de los compuestos anteriormente mencionados en el control o prevencion de enfermedades tales como el cancer.
MXPA05010135A 2003-03-28 2004-03-26 Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos. MXPA05010135A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03007124 2003-03-28
US45974103P 2003-04-02 2003-04-02
PCT/EP2004/003205 WO2004085434A1 (en) 2003-03-28 2004-03-26 Novel oxazole derivatives, their manufacture and use as pharmaceutical agents

Publications (1)

Publication Number Publication Date
MXPA05010135A true MXPA05010135A (es) 2005-11-16

Family

ID=36748274

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010135A MXPA05010135A (es) 2003-03-28 2004-03-26 Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos.

Country Status (18)

Country Link
US (1) US7205325B2 (es)
EP (1) EP1613623A1 (es)
JP (1) JP2006515019A (es)
KR (1) KR100842692B1 (es)
CN (1) CN100386325C (es)
AR (1) AR043920A1 (es)
AU (1) AU2004224173A1 (es)
BR (1) BRPI0408826A (es)
CA (1) CA2519053A1 (es)
CL (1) CL2004000630A1 (es)
CO (1) CO5611130A2 (es)
HR (1) HRP20050831A2 (es)
MX (1) MXPA05010135A (es)
NO (1) NO20054360L (es)
RU (1) RU2005133073A (es)
TW (1) TW200505913A (es)
WO (1) WO2004085434A1 (es)
ZA (1) ZA200506953B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005526B2 (en) 2004-05-25 2006-02-28 Hoffmann-La Roche Inc. Thioether derivatives
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
TW200738680A (en) 2005-08-04 2007-10-16 Hoffmann La Roche Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
CA2616075A1 (en) * 2005-08-08 2007-02-15 Hans-Willi Krell Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
SI1954684T1 (sl) * 2005-11-15 2014-07-31 Otsuka Pharmaceutical Co., Ltd. Oksazolna spojina in farmacevtski sestavek
CA2995617A1 (en) * 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK531479A (da) 1979-01-19 1980-07-20 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
GR71915B (es) 1979-11-27 1983-08-16 Pfizer
DE3808283A1 (de) 1988-03-12 1989-09-21 Boehringer Ingelheim Kg Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung
US5359078A (en) 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
US5281593A (en) 1990-07-31 1994-01-25 Lilly Industries Limited Certain indole derivatives useful as leukotriene antagonists
GB9122590D0 (en) 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
US5322847A (en) 1992-11-05 1994-06-21 Pfizer Inc. Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
EP0754683B1 (en) 1994-04-08 2002-08-14 Sumitomo Chemical Company Limited Ether compound, use thereof, and intermediate for producing the compound
US5883106A (en) 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
JPH09136877A (ja) 1995-06-16 1997-05-27 Takeda Chem Ind Ltd 複素環化合物、その製造法及び用途
DE19610882A1 (de) 1996-03-20 1997-09-25 Dresden Arzneimittel Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO1998003505A2 (en) 1996-07-19 1998-01-29 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
US6156748A (en) 1996-10-07 2000-12-05 Eli Lilly And Company Compounds useful as neuro-protective agents
PE20011178A1 (es) * 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
EP1439178A4 (en) 2001-10-05 2005-11-16 Takeda Pharmaceutical HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR THEIR PRESENTATION AND USE THEREOF
AU2003203170A1 (en) 2002-01-17 2003-07-30 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof

Also Published As

Publication number Publication date
BRPI0408826A (pt) 2006-04-04
CO5611130A2 (es) 2006-02-28
CN100386325C (zh) 2008-05-07
EP1613623A1 (en) 2006-01-11
AU2004224173A1 (en) 2004-10-07
US20040209933A1 (en) 2004-10-21
KR20050118688A (ko) 2005-12-19
RU2005133073A (ru) 2006-06-10
TW200505913A (en) 2005-02-16
ZA200506953B (en) 2006-05-31
JP2006515019A (ja) 2006-05-18
KR100842692B1 (ko) 2008-07-01
CL2004000630A1 (es) 2005-02-04
CA2519053A1 (en) 2004-10-07
CN1764660A (zh) 2006-04-26
NO20054360L (no) 2005-10-11
WO2004085434A1 (en) 2004-10-07
HRP20050831A2 (en) 2006-09-30
US7205325B2 (en) 2007-04-17
AR043920A1 (es) 2005-08-17

Similar Documents

Publication Publication Date Title
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
WO2006066914A3 (en) Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors
WO2006066913A3 (en) Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors
MX2009002010A (es) Derivados de heteroarilo como inhibidores de la proteina cinasa.
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
MY127369A (en) Quinazoline derivatives
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
IL191748A0 (en) 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
MX2008011769A (es) Derivados de ftalazinona pirazol, su fabricacion y uso como agentes farmaceuticos.
NO20054360L (no) Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater
IL198630A0 (en) Pyrimidyl derivatives as protein kinase inhibitors
TW200736220A (en) Pyridylsulfonamide derivatives, their manufacture and use as pharmaceutical agents
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
MXPA05011671A (es) Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos.
TW200626149A (en) Tricycles, their manufacture and use as pharmaceutical agents
WO2005016921A3 (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
MX2008001412A (es) Derivados de fenilpiridina, su obtencion y su utilizacion como agentes farmaceuticos.
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders

Legal Events

Date Code Title Description
FG Grant or registration